메디채널

주메뉴 바로가기
본문 바로가기

기상청 제공

닫기

전체기사

FrankieOne and MATTR unite to strengthen digital identity assurance with verifiable, government-issued credentials

[ 메디채널 황정호 기자 ] Embed privacy-preserving credential checks alongside today's KYC/KYB/AML flows—improving assurance at onboarding, payments, and account servicing. MELBOURNE, Australia, Oct. 23, 2025 -- FrankieOne and MATTR announced a partnership to make standards-backed verifiable digital credentials available within FrankieOne's identity and compliance orchestration platform—placing cryptographic proof directly into the risk decisioning flows enterprises already use. The collaboration embeds MATTR's digital trust technology into FrankieOne's identity orchestration platform,
- 황정호 기자
- 2025-10-23 06:00
Natural History Museum Abu Dhabi to Open in Saadiyat Cultural District on 22 November

ABU DHABI, UAE, Oct. 23, 2025 -- The Natural History Museum Abu Dhabi will open to the public on 22 November in Saadiyat Cultural District, marking a significant cultural milestone for the emirate. As the largest museum of its kind in the region, it represents a new global destination for science, nature, and education, inviting visitors to explore the story of life on our planet and engage in conversations about its future. The 35,000-square-metre museum is an exciting addition to the UAE's evolving cultural landscape. It takes visitors on an immersive journey through 13.8 bil
- 김장윤(JASON KIM) 기자
- 2025-10-23 04:15
Telix Doses First Patient in SOLACE Trial for Metastatic Bone Pain

MELBOURNE, Australia and INDIANAPOLIS, Oct. 23, 2025 -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces that it has dosed the first patient in a Phase 1 clinical trial of TLX090 (153Samarium (Sm)-DOTMP), a therapeutic radiopharmaceutical candidate for treating pain associated with bone metastasis. TLX090 is designed to deliver targeted radiation to bone tumors while minimizing damage to surrounding healthy tissues. SOLACE (Samarium Optimized for Long-lasting Analgesia in Cancerous End-stage bone pain) is an open-label Phase
- 김갑성 기자
- 2025-10-23 04:00
Phoenix Aviation Capital and AIP Capital Announce Upsize of Senior Secured Credit Facility to $550 Million

DUBLIN and STAMFORD, Conn. and NEW YORK, Oct. 23, 2025 -- Phoenix Aviation Capital ("Phoenix" or "the Company"), a full-service aircraft lessor managed by AIP Capital ("AIP"), an alternative investment manager focused on opportunities in asset-based finance and a portfolio company of funds advised or controlled by affiliates of BC Partners Advisors L.P., announced a $250 million upsize to its $300 million senior secured credit facility ("the facility"), bringing total commitments to the facility to $550 million. HSBC, Truist, Fifth Third
- 황정호 기자
- 2025-10-23 03:00
Nature Wood Group Limited Announces Change in Controlling Shareholder Following Completion of Private Share Transfer

MACAU, Oct. 23, 2025 -- Nature Wood Group Limited (Nasdaq: NWGL) ("Nature Wood" or the "Company"), a global leading vertically-integrated forestry company headquartered in Macau, today announced a change in its controlling shareholder following the closing of a private transaction. On October 22, 2025, the board of directors of the Company was notified that Mr. SE Hok Pan, Easy Bliss Limited, Linking Stars Limited, More Choice Global Limited, Mr. CHAN Wing Luk and Mr. HUANG Qing Cai (collectively, the "Sellers") completed the transfer of an aggregate of 11
- 황정호 기자
- 2025-10-23 02:31
Charming Medical Limited Announces Closing of Initial Public Offering

HONG KONG, Oct. 23, 2025 -- Charming Medical Limited (Nasdaq: MCTA) (the "Company"), a Hong Kong-based provider of Traditional Chinese Medicine (TCM)-inspired therapies and products, today announced the closing of its initial public offering (the "Offering") of 1,600,000 Class A ordinary shares, par value $0.0001 per share (the "Class A Ordinary Shares") at a price of $4.00 per share (the "Public Offering Price"). The Company's Class A Ordinary Shares began trading on the Nasdaq Capital Market under the symbol "MCTA" on October 21, 2025.
- 황정호 기자
- 2025-10-23 00:51
SynbioTech Brings Taiwan's Biotech Excellence to the Global Stage with TWK10® for Muscle Performance and Healthy Aging

LAS VEGAS, Oct. 23, 2025 -- In a field where scientific validation defines credibility, Synbio Tech Inc., a biotechnology company from Taiwan, is gaining international recognition with its proprietary probiotic Lactiplantibacillus plantarum TWK10®. The clinically proven strain, which will be featured at SupplySide Global 2025 from October 27–30 (Booth #6253F), has shown measurable benefits on muscle strength, endurance, and balance—offering a new microbiome-based approach to healthy aging and active living. Backed by over a decade of research, TWK10® has been evaluated
- 김갑성 기자
- 2025-10-23 00:00
Largest Milestone Payment Secured: Biokin, a Rising Chinese Pharmaceutical MNC

BEIJING, Oct. 22, 2025 -- In October 2025, a partnership between Biokin—a rising star in China's innovative pharmaceutical sector—and global pharmaceutical leader BMS triggered a $250 million milestone payment. This is believed to be the largest antibody-drug conjugate (ADC) milestone payment among hundreds of out-licensing deals involving Chinese innovative drugs. Notably, the overall transaction had previously set a record for the total value of a single-drug asset license in China. In recent years, China's dynamic pharmaceutical ecosystem has rapidly emerged as one of the wo
- 김갑성 기자
- 2025-10-22 23:39
The Blood Center in New Orleans modernizes platelet processing with FDA-cleared automation from Terumo Blood and Cell Technologies

— Second U.S. site to deploy the Reveos™ system, boosting platelet supply and reducing waste LAKEWOOD, Colo., Oct. 22, 2025 -- To help address platelet shortages and streamline blood center operations, The Blood Center in New Orleans has become the second U.S. blood center to implement the Reveos™ Automated Blood Processing System and the Lumia™ Software Platform from Terumo Blood and Cell Technologies (Terumo BCT), a medical technology company and global leader in blood management solutions. The move marks a significant step forward in transforming how blood centers process bl
- 김갑성 기자
- 2025-10-22 22:39
Invitation to Electrolux Group Capital Markets Update, December 4, 2025

STOCKHOLM, Oct. 22, 2025 -- Electrolux Group has the pleasure of inviting investors, financial analysts and business media representatives to its Capital Markets Update on December 4, 2025. The Capital Markets Update (CMU) will be held at Electrolux Group headquarters on S:t Göransgatan 143 in Stockholm, Sweden, starting at 14.00 CET on December 4, 2025, with registration from 13.30 CET. A live webcast will also be available. The agenda will include presentations by Yannick Fierling, President and CEO, and members of the Group Management team between 14.00 CET and approx. 1
- 황정호 기자
- 2025-10-22 22:36

이전

1 2 3 4 5 6 7 8 9 10

많이 본 기사

최근기사

2025-10-24_FRI

World Psoriasis Day 2025: IFPA Calls to Stop the Domino Effect of Psoriasis 00:13

2025-10-23_THU

발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.

UPDATE: 2025년 10월 24일 01시 40분